Korro Bio, Inc. Operating Lease, Payments
Korro Bio, Inc. (KRRO) reported Operating Lease, Payments of $484.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2021-03-29
- Korro Bio, Inc. operating lease, payments for the quarter ending 2020-12-31 was $212.00K.
- Korro Bio, Inc. operating lease, payments for the quarter ending 2020-09-30 was $101.00K.
- Korro Bio, Inc. operating lease, payments for the quarter ending 2020-06-30 was $99.00K.
- Korro Bio, Inc. operating lease, payments for the quarter ending 2020-03-31 was $72.00K.
- Korro Bio, Inc. operating lease, payments for fiscal 2020 was $484.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $313.00K derived: sum of 2 quarters · filed 2021-03-29 | $412.00K derived: sum of 3 quarters · filed 2021-03-29 | $484.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $200.00K derived: sum of 2 quarters · filed 2020-11-16 | $272.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $171.00K 10-Q · filed 2020-08-12 | ||
| 2020-03-31 | $72.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |